Were QTREX Quantum (QTEX) CFO share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state the securities were sold pursuant to an existing Rule 10b5-1 plan. Such plans pre-schedule trades in advance, meaning the timing of these sales was determined earlier rather than based on day-to-day market conditions.

QTREX Quantum CFO sells 60,000 shares in plan

QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales of a total of 60,000 Ordinary Shares of QTEX at prices between $2.0134 and $3.00 per share.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales of a total of 60,000 Ordinary Shares of QTEX at prices between $2.0134 and $3.00 per share. Following these transactions, she directly holds 900,000 Ordinary Shares.

On the same dates, she exercised employee share options covering 13,605 Ordinary Shares at a conversion price of $0.12 per share, with no derivative options remaining after the exercise. The sales were executed pursuant to an existing Rule 10b5-1 trading plan, indicating they were pre-arranged rather than timed discretionarily.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 6 txns

Insider Tehila Yafit

Role Chief Financial Officer

Sold 60,000 shs ($144K)

Approx. gross sale proceeds $144K

Approx. exercise cost $2K

Type	Security	Shares	Price	Value
Exercise	Employee share options (right to buy)	13,605	$0.00	$0.00
Sale	Ordinary Shares	15,000	$2.56	$38K
Sale	Ordinary Shares	15,000	$3.00	$45K
Exercise	Ordinary Shares	13,605	$0.12	$2K
Sale	Ordinary Shares	13,605	$2.0251	$28K
Sale	Ordinary Shares	16,395	$2.0134	$33K

Holdings After Transaction: Employee share options (right to buy) — 0 contracts (Direct); Ordinary Shares — 900,000 shares (Direct)

Footnotes (2)

F1. The options were granted on February 21, 2021 and became fully vested as of February 23, 2024.
F2. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

Key Figures

Shares sold: 60,000 shares Sale prices: $2.0134–$3.00 per share Post-transaction holdings: 900,000 shares +4 more

7 metrics

Shares sold 60,000 shares Total Ordinary Shares sold in open-market transactions

Sale prices $2.0134–$3.00 per share Price range for Ordinary Share sales on May 27–28 2026

Post-transaction holdings 900,000 shares Ordinary Shares directly held by CFO after trades

Options exercised 13,605 shares Employee share options converted into Ordinary Shares

Option exercise price $0.12 per share Conversion price for exercised employee share options

Highest sale price $3.00 per share Open-market sale of 15,000 shares on May 28 2026

Lowest sale price $2.0134 per share Open-market sale of 16,395 shares on May 27 2026

Key Terms

Rule 10b5-1 plan, open-market sale, Employee share options (right to buy), Exercise or conversion of derivative security, +1 more

5 terms

Rule 10b5-1 plan regulatory

"The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open-market sale financial

"transaction_action: "open-market sale" for the Ordinary Shares transactions"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Exercise or conversion of derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security" for code M"

Ordinary Shares financial

"security_title: "Ordinary Shares" for the non-derivative transactions"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did QTREX Quantum (QTEX) report for its CFO?

QTREX Quantum’s CFO, Tehila Yafit, reported selling a total of 60,000 Ordinary Shares in open-market transactions. These sales occurred at prices between $2.0134 and $3.00 per share over two days and were executed under a pre-existing Rule 10b5-1 plan.

How many QTREX Quantum (QTEX) shares does the CFO hold after the Form 4 trades?

After the reported transactions, CFO Tehila Yafit directly holds 900,000 Ordinary Shares of QTREX Quantum. This figure reflects her position following the sale of 60,000 shares and the exercise of options for 13,605 shares disclosed in the same Form 4.

Did the QTREX Quantum (QTEX) CFO exercise any stock options in this filing?

Yes. Tehila Yafit exercised employee share options for 13,605 Ordinary Shares at a conversion price of $0.12 per share. The options were originally granted on February 21, 2021 and had become fully vested as of February 23, 2024, according to the footnotes.

What transaction pattern does the QTREX Quantum (QTEX) Form 4 show for the CFO?

The Form 4 shows an exercise-and-sell pattern. The CFO exercised options for 13,605 Ordinary Shares, then reported multiple open-market sales totaling 60,000 shares. After these trades, she retains 900,000 shares, indicating she continues to hold a substantial direct equity position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/29/2026 - 03:12 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tehila Yafit

(Last)

(First)

(Middle)

2 HA-TIDHAR ST.

(Street)

RA'ANANA

4366504

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QTREX Quantum Ltd. [ QTEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	05/27/2026		M		13,605⁽²⁾	A	$0.12	960,000	D
Ordinary Shares	05/27/2026		S		13,605⁽²⁾	D	$2.0251	946,395	D
Ordinary Shares	05/27/2026		S		16,395⁽²⁾	D	$2.0134	930,000	D
Ordinary Shares	05/28/2026		S		15,000⁽²⁾	D	$2.56	915,000	D
Ordinary Shares	05/28/2026		S		15,000⁽²⁾	D	$3	900,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee share options (right to buy)	$0.12	05/28/2026		M			13,605⁽²⁾	⁽¹⁾	02/21/2031	Ordinary Shares	13,605	$0	0	D

Explanation of Responses:

1. The options were granted on February 21, 2021 and became fully vested as of February 23, 2024.

2. The securities were sold by the Reporting Person pursuant to an existing 10b5-1 plan.

	/s/ Yafit Tehila	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR